Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- CORPORATE ROUNDUP NEWS IN BRIEF
December 22, 2003
- NEW PRODUCTS
December 22, 2003
- Virtual Heart Should Improve Drug Development Success Rates: Dr Noble
December 22, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
December 22, 2003
- Sankyo Wishes to Obtain 75% Statin Share: President Shoda
December 22, 2003
- Sales of In Vitro Diagnostics Rose 1.5% in FY2002: JACR
December 22, 2003
- WORLD NEWS IN BRIEF
December 22, 2003
- DIAGNOSTIC NEWS IN BRIEF
December 22, 2003
- Dainippon Sees 3 New Drugs as Potential Blockbusters
December 22, 2003
- Semi-annual Business Results
December 22, 2003
- Japanese Industry to Participate in Negotiations on PPRS: JPMA-ABPI Conference
December 22, 2003
- BULLETIN
December 22, 2003
- BUSINESS NEWS IN BRIEF
December 22, 2003
- Segami Medics Aims for \100 Bil. Sales as Early as Possible
December 22, 2003
- Payers Clash with Healthcare Providers on Medical Fee Revision
December 22, 2003
- OTC NEWS IN BRIEF
December 22, 2003
- 4th Proposal on Special Structural Reform Zones Finalized
December 22, 2003
- MEDICAL DEVICE NEWS IN BRIEF
December 22, 2003
- REGULATORY NEWS IN BRIEF
December 22, 2003
- Malzen to Merge with Shinyakudo in May 2004
December 22, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…